Mogamulizumab (KW-0761) is a monoclonal antibody targeting T cell CC chemokine receptor 4. It exhibits anticancer activity by eliminating tumor cells through antibody-dependent cytotoxicity (ADCC) and can be used in the study of cancer, adult T-cell leuk
CAS Number:
[1159266-37-1]
Target:
CXCR
* VAT and and shipping costs not included. Errors and price changes excepted